scispace - formally typeset
A

Annette Fieldstone

Researcher at Ohio State University

Publications -  5
Citations -  954

Annette Fieldstone is an academic researcher from Ohio State University. The author has contributed to research in topics: Vagal tone & Autonomic nervous system. The author has an hindex of 5, co-authored 5 publications receiving 907 citations.

Papers
More filters
Journal ArticleDOI

Autonomic cardiac control. III. Psychological stress and cardiac response in autonomic space as revealed by pharmacological blockades.

TL;DR: Analysis of the effects of pharmacological blockades revealed an overall pattern of increased sympathetic and decreased parasympathetic control of the heart during speech stress, mental arithmetic, and a reaction-time task, which reflected notable individual differences in the mode of autonomic response to stress, which had considerable stability across stress tasks.
Journal ArticleDOI

Autonomic cardiac control. II: Noninvasive indices and basal response as revealed by autonomic blockades

TL;DR: Analyses of the blockade data revealed that the preejection period (PEP) reflected sympathetic but not vagal influences on the heart, and high frequency (HF, 0.12-0.40 Hz) heart rate variability (respiratory sinus arrhythmia) reflected vagal but not sympathetic influences onThe heart.
Journal ArticleDOI

Illusions, arithmetic, and the bidirectional modulation of vagal control of the heart.

TL;DR: Neither PEP nor RSA responses were correlated across the illusion and arithmetic tasks, which may be attributable to the dissimilar modes of autonomic control evoked by these tasks.
Journal ArticleDOI

Food preferences in Prader-Willi syndrome, normal weight and obese controls

TL;DR: The obesity of PWS was shown to have a significant and distinctly different food preference profile from normal weight and obese controls, in accord with the growing recognition of functional subgroups within the obese population.
Journal ArticleDOI

Food intake in Prader-Willi syndrome and controls with obesity after administration of a benzodiazepine receptor agonist.

TL;DR: Results suggest that acute administration of the BZR agonist CDP, at the therapeutic levels used, may not increase food intake in populations with obesity, however, the chronic effects of CDP on appetite in human populations still need to be explored.